TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TYK Medicines, Inc. Class H ( (HK:2410) ) has issued an announcement.
TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, has announced the composition of its board of directors and their respective roles within the company. The board comprises executive, non-executive, and independent non-executive directors, with Dr. Wu Yusheng serving as the executive director. The announcement also details the membership of four board committees, highlighting the roles of each director within these committees. This organizational update reflects the company’s commitment to structured governance and may influence its strategic decision-making and operational efficiency.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 6,367,688
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$5.5B
For a thorough assessment of 2410 stock, go to TipRanks’ Stock Analysis page.